Search

Author/Creator Hassan, Omnia Babekir

1. S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan—top line results. (20th September 2022)

Authors:
Fahal, Ahmed Hassan; Bakhiet, Sahar Mubarak; Mohamed, El Samani Wadaa; Ahmed, Eiman Siddig; Bakhiet, Osama El Hadi; Yousif, Abu Bakar Ahmed; Fahal, Lamis Ahmed; Alla, Hadel Yassir Atta; Razig, A Razig Osman A; Siddig, Emmanuel Edwar; Hassan, Omnia Babekir; Abdulla, Sahar A Rahman; Mohaemd, Amir F...
Journal:
Medical mycology
Issue:
Volume 60(2022)supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Staphylococcus aureus causing primary foot botryomycosis mimicking actinomycetoma: a case report from Sudan. (November 2022)

Authors:
Siddig, Emmanuel Edwar; Nyuykonge, Bertrand; Bakheit, Osama EL Hadi; Hassan, Omnia Babekir; Ahmed, Eiman Siddig; Osman, Asma Adam; Bakhiet, Sahar Mubarak; van de Sande, Wendy WJ; Fahal, Ahmed Hassan
Journal:
International journal of infectious diseases
Issue:
Volume 124(2022)
Page Start:
224
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search